BridgeMD
New treatment option for Neurofibromatosis 1
Official title Tailoring an Online Platform to Promote Evidence-Based Care for Adults With Neurofibromatosis 1 and Low Health Literacy
ClinicalTrials.gov ID: NCT07233408
What this study is testing
- What it's testing
- This decentralized, randomized study seeks to assess the feasibility, acceptability, and preliminary effectiveness of two approaches to assisting Neurofibromatosis 1 (NF1) patients with low health literacy improve their understanding of NF1 symptoms and care recommendations. Participants will be provided with personalized NF1 care letters for themselves and their doctors, along with either NF1 educational videos or a call with an NF1 peer navigator.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥18 years
- Currently lives in the United States
- Has a clinical diagnosis of Neurofibromatosis 1
- Speaks English
- Has low health literacy as ascertained by standardized instruments
You likely can't join if
- Unwilling or unable to give informed consent
- Is too cognitively impaired to participate in the opinion of the study investigator (e.g. any cognitive or developmental delay that prevents...
- Was enrolled in or is the parent or guardian of a participant enrolled in assigned by chance clinical trial NCT06262113
See the full eligibility criteria
- Age ≥18 years
- Currently lives in the United States
- Has a clinical diagnosis of Neurofibromatosis 1
- Speaks English
- Has low health literacy as ascertained by standardized instruments
- Has an in-person, well-person visit (e.g. not a visit to address an acute medical issue) with their primary care provider (PCP) scheduled within the 3 months following their consent
- Unwilling or unable to give informed consent
- Is too cognitively impaired to participate in the opinion of the study investigator (e.g. any cognitive or developmental delay that prevents completion of study questionnaires)
- Was enrolled in or is the parent or guardian of a participant enrolled in assigned by chance clinical trial NCT06262113
The study team makes the final eligibility decision.
Where it's taking place
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Boston, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.